Citation Impact
Citing Papers
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
The effect of l ‐thyroxine treatment on chronic idiopathic urticaria and autoimmune thyroiditis
2011
Levocetirizine
2006
Platelets: at the nexus of antimicrobial defence
2014
Soluble IgE receptors—Elements of the IgE network
2011
IgE and mast cells in allergic disease
2012 Standout
Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
1990 Standout
Nonresolving Inflammation
2010 Standout
The role of platelets in the pathophysiology of asthma
2007
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The development of allergic inflammation
2008 StandoutNature
NET balancing: a problem in inflammatory lung diseases
2013
Mast Cell Biology: Introduction and Overview
2011
Measures of preoperative anxiety
2019 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
LAG-3 in Cancer Immunotherapy
2010
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
2010
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
2009
PharmGKB summary
2011
APD3: the antimicrobial peptide database as a tool for research and education
2015 Standout
Urticaria and Thyroid Autoimmunity
2011
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Protective Role of 14-Deoxy-11,12-didehydroandrographolide, a Noncytotoxic Analogue of Andrographolide, in Allergic Airway Inflammation
2011 Standout
Immunology of Psoriasis
2014 Standout
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Anxiety in patients undergoing fast-track knee arthroplasty in the light of recent literature.
2014
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Tissue effects of glucocorticoids
1972
Allergen injection immunotherapy for seasonal allergic rhinitis
2007
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation
2018 StandoutNobel
Works of Barbara Rogala being referenced
Platelet-Activating Factor (PAF): A Review of its Role in Asthma and Clinical Efficacy of PAF Antagonists in the Disease Therapy
2008
EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria
2009
Platelet function in cutaneous diseases
2008
EAACI/GA²LEN/EDF/WAO guideline: management of urticaria
2009
Circulating Levels of Urokinase-Type Plasminogen Activator (uPA) and its Soluble Receptor (suPAR) in Patients with Atopic Eczema/Dermatitis Syndrome
2006
Anxiety and depression and their influence on the quality of life after total hip replacement: preliminary report
2008
Seasonal Changes in Platelet Activity in Pollen-Induced Seasonal Allergic Rhinitis and Asthma
2008
Platelet Activation During Allergic Inflammation
2007
Enhanced Platelet Activation in Patients with Atopic Eczema/Dermatitis Syndrome
2004
[Molecular mechanism of glucocorticoid action].
1996
[Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
2004
Platelet Activating Factor as a Mediator and Therapeutic Approach in Bronchial Asthma
2008
Soluble CD23 in allergic diseases.
1999
Do the molecules CD26 and lymphocytes activation gene-3 differentiate between type 1 and 2 T cell response?
2002
Platelet aggregation in IgE-mediated allergy with elevated soluble Fc epsilon RII/CD23 level.
1995